Cambridge Healthtech Institute’s 12th Annual
Cell Therapy CMC & Manufacturing
June 16-17, 2027
Cambridge Healthtech Institute’s 12th Annual Cell Therapy CMC & Manufacturing conference addresses persistent challenges in production timelines, cost, and scalability as cell therapies expand in oncology and beyond. Across CAR-T, TCR-T, NK, TIL, iPSC-derived, and other ex vivo cell therapies, the program will highlight strategies for more robust and commercially viable manufacturing. Key themes include automation and digitization, emerging applications of AI and machine learning, tech transfer and scale-out, and analytical lessons that inform manufacturing decisions and product quality. As the field navigates recent setbacks and new opportunities in areas such as autoimmune disease, discussions will focus on practical innovations for faster, more efficient cell therapy manufacturing.
Coverage will include, but is not limited to:
- Process Development, Product Analytics & Product Quality
- Cell culture, expansion, and process optimization
- Potency assay strategies, functional characterization, and critical quality attributes
- Analytical strategies for linking critical quality attributes to process performance
- Accelerating QC and batch release
- Process intensification/reducing manufacturing time
- AI, Digitalization, Automation & Patient-Centric Manufacturing
- Closed, single-use, and automated manufacturing technologies
- Fresh versus cryopreserved manufacturing strategies
- Patient-specific manufacturing challenges
- starting-material variability, chain of identity/custody at scale, and consistency across individualized batches
- Centralized versus distributed manufacturing models
- Scaling manufacturing capacity while maintaining product consistency
- Commercial Manufacturing, Tech Transfer & Multisite Expansion
- Clinical-to-commercial manufacturing readiness
- Technology transfer between development, internal manufacturing sites, and CDMOs
- Comparability following manufacturing changes
- including changes in site, equipment, raw materials, scale, or process
- Scale-out, capacity, and cost-of-goods strategies
The deadline for priority consideration is November 20, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation:
- To submit a podium presentation, please click here.
- To become a sponsor, click here.
- To present a poster, click here.
- To sign up to attend, click here.